From: Sex differences in cancer survival in Estonia: a population-based study
Cancer site | EHR (95% CI)* | EHR adjusted for age (95% CI) | EHR adjusted for age and extent (95% CI) | EHR adjusted for age, extent and subsite** (95% CI) |
---|---|---|---|---|
Mouth, pharynx | 0.54 (0.46–0.63) | 0.54 (0.46–0.64) | 0.60 (0.51–0.71) | 0.66 (0.56–0.78) |
Stomach | 0.92 (0.86–0.98) | 0.88 (0.82–0.94) | 0.90 (0.84–0.96) | 0.91 (0.85–0.97) |
Colon | 1.05 (0.96–1.15) | 1.01 (0.92–1.11) | 1.10 (1.00–1.21) | 1.09 (0.99–1.19) |
Rectum | 0.98 (0.88–1.10) | 0.92 (0.83–1.03) | 1.00 (0.90–1.11) | 0.99 (0.89–1.10) |
Pancreas | 1.00 (0.91–1.09) | 0.94 (0.85–1.03) | 0.97 (0.88–1.06) | |
Lung | 0.90 (0.85–0.96) | 0.87 (0.82–0.93) | 0.81 (0.76–0.86) | |
Skin melanoma | 0.53 (0.43–0.66) | 0.52 (0.43–0.64) | 0.68 (0.55–0.84) | 0.72 (0.58–0.90) |
Kidney | 0.76 (0.67–0.87) | 0.72 (0.63–0.83) | 0.81 (0.70–0.93) | |
Bladder | 1.03 (0.86–1.24) | 0.92 (0.77–1.11) | 0.96 (0.80–1.15) |